Original Research
Published on 29 Jul 2025
Discovery of a selective dual-specificity tyrosine phosphorylation-regulated kinase 1B inhibitor with anti-adipogenic and anti-diabetic activities
in Experimental Pharmacology and Drug Discovery
- 392 views